First Trust Indxx Medical Devices ETF Rating → Warren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector… (From InvestorPlace) (Ad) Free MDEV Stock Alerts $20.36 +0.10 (+0.49%) (As of 05/31/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsOwnershipRatingsStock AnalysisChartHoldingsOwnershipRatings First Trust Indxx Medical Devices ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.MDEV Aggregate RatingModerate Buy2.58Holdings in MDEV have an aggregate rating of Moderate Buy based on 373 analyst ratings issued in the past year covering 31 companies (60.7% of the portfolio).MDEV Aggregate Price Target$23.7216.50% UpsideHigh Prediction$28.02Average Prediction$23.72Low Prediction$18.80Holdings in MDEV have an aggregate price target of $23.72 and a range of $18.80 to $28.02 covering 31 companies (60.7% of the portfolio).MDEV Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy24 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust Indxx Medical Devices ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 31 MDEV Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.52%GMEDGlobus Medical$67.11+0.8%5 of 5 stars2.64$69.40 3.4%11Analyst ForecastShort Interest ↓Analyst RevisionPositive News2.28%MTDMettler-Toledo International$1,404.09+1.5%4 of 5 stars2.14$1,257.14 -10.5%7Analyst RevisionPositive News2.22%RMDResMed$206.33-1.4%5 of 5 stars2.70$202.80 -1.7%10Analyst RevisionHigh Trading Volume2.20%BSXBoston Scientific$75.57+0.8%5 of 5 stars2.95$76.70 1.5%22Analyst ForecastInsider SellingShort Interest ↓2.18%STESTERIS$222.88-0.2%4 of 5 stars2.50$241.60 8.4%6Analyst DowngradeAnalyst Revision2.15%RVTYRevvity$109.26+0.8%2 of 5 stars2.54$118.17 8.2%13News CoveragePositive News2.15%DHRDanaher$256.80+1.6%4 of 5 stars2.64$267.31 4.1%14Short Interest ↑Positive NewsHigh Trading Volume2.10%AAgilent Technologies$130.41-0.8%5 of 5 stars2.56$137.19 5.2%16Earnings ReportAnalyst ForecastShort Interest ↓Analyst RevisionNews CoverageHigh Trading Volume2.08%ISRGIntuitive Surgical$402.12-0.3%4 of 5 stars2.78$403.67 0.4%18Analyst ForecastInsider SellingShort Interest ↑2.05%WATWaters$308.90+0.4%4 of 5 stars1.90$305.78 -1.0%10Insider BuyingAnalyst RevisionHigh Trading Volume2.04%MDTMedtronic$81.37+1.0%5 of 5 stars2.25$93.00 14.3%12Analyst Forecast2.03%SWAVShockwave Medical$334.754 of 5 stars2.09$309.11 -7.7%11Positive News2.02%PODDInsulet$177.19+0.7%5 of 5 stars2.83$239.18 35.0%18Analyst ForecastInsider SellingShort Interest ↑2.02%TMOThermo Fisher Scientific$567.98+0.9%5 of 5 stars2.71$605.31 6.6%17Positive News1.97%SYKStryker$341.09+0.2%5 of 5 stars2.79$370.58 8.6%19Analyst ForecastPositive News1.95%COOCooper Companies$94.31+4.5%3 of 5 stars2.73$111.42 18.1%11Earnings ReportAnalyst ForecastShort Interest ↑News CoverageGap UpHigh Trading Volume1.92%BDXBecton, Dickinson and Company$231.97+2.3%5 of 5 stars2.83$280.17 20.8%6Analyst ForecastShort Interest ↓High Trading Volume1.92%EWEdwards Lifesciences$86.89-1.1%5 of 5 stars2.65$95.06 9.4%20Analyst ForecastInsider SellingShort Interest ↓High Trading Volume1.90%TFXTeleflex$209.07+1.2%4 of 5 stars2.63$257.29 23.1%8Short Interest ↑Analyst RevisionHigh Trading Volume1.90%BIOBio-Rad Laboratories$286.86+1.7%5 of 5 stars2.80$461.00 60.7%5Analyst UpgradeShort Interest ↓Analyst Revision1.89%HOLXHologic$73.78+1.7%5 of 5 stars2.55$85.60 16.0%111.86%DXCMDexCom$118.77+0.3%5 of 5 stars2.87$140.94 18.7%15Analyst ForecastShort Interest ↓High Trading Volume1.84%ABTAbbott Laboratories$102.19+0.4%5 of 5 stars2.70$120.64 18.1%10Analyst Forecast1.84%MASIMasimo$124.50-1.3%5 of 5 stars2.43$138.71 11.4%7Short Interest ↓Analyst RevisionPositive News1.83%ZBHZimmer Biomet$115.15+0.6%5 of 5 stars2.31$133.75 16.2%16Analyst ForecastShort Interest ↑High Trading Volume1.82%GEHCGE HealthCare Technologies$78.00-0.7%4 of 5 stars2.55$94.09 20.6%11Analyst ForecastInsider SellingShort Interest ↓Positive NewsHigh Trading Volume1.76%PENPenumbra$189.47+0.8%5 of 5 stars2.70$300.64 58.7%101.71%WSTWest Pharmaceutical Services$331.41+0.7%5 of 5 stars2.80$435.20 31.3%5Positive News1.67%BAXBaxter International$34.09+2.8%5 of 5 stars2.18$44.42 30.3%11Analyst ForecastShort Interest ↓1.57%ALGNAlign Technology$257.21+0.3%5 of 5 stars2.50$353.00 37.2%10Short Interest ↑Positive News1.31%EXASExact Sciences$45.45+0.4%4 of 5 stars2.92$95.40 109.9%13Gap Down This page (BATS:MDEV) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust Indxx Medical Devices ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
